Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Friede

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Sub-Cellular Biochemistry|July 2, 2010
Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvantsChristopher B Fox, Martin Friede, Steven G Reed, et al.
The Lancet. Infectious Diseases|February 5, 2019
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaborationJohan Vekemans, Nebiat Gebreselassie, Matteo Zignol, et al.
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
Vaccine|June 6, 2018
Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availabilityJan Hendriks, Raymond C W Hutubessy, Gary Grohmann, et al.
Vaccine|October 6, 2024
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impactJessica Taaffe, Julia T Ostrowsky, Joshua Mott, et al.
Vaccine|June 21, 2011
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transferMartin Friede, Laszlo Palkonyay, Claudia Alfonso, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Vaccine|June 28, 2008
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007Maryna Eichelberger, Hana Golding, Maureen Hess, et al.
Vaccine|December 18, 2022
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030David Sarley, Angela Hwang, B Fenton Hall, et al.
Vaccine|September 4, 2007
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humansNathalie Etchart, Ana Hennino, Martin Friede, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Sub-Cellular Biochemistry|July 2, 2010
Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvantsChristopher B Fox, Martin Friede, Steven G Reed, et al.
The Lancet. Infectious Diseases|February 5, 2019
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaborationJohan Vekemans, Nebiat Gebreselassie, Matteo Zignol, et al.
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
Vaccine|June 6, 2018
Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availabilityJan Hendriks, Raymond C W Hutubessy, Gary Grohmann, et al.
Vaccine|October 6, 2024
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impactJessica Taaffe, Julia T Ostrowsky, Joshua Mott, et al.
Vaccine|June 21, 2011
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transferMartin Friede, Laszlo Palkonyay, Claudia Alfonso, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Vaccine|June 28, 2008
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007Maryna Eichelberger, Hana Golding, Maureen Hess, et al.
Vaccine|December 18, 2022
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030David Sarley, Angela Hwang, B Fenton Hall, et al.
Vaccine|September 4, 2007
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humansNathalie Etchart, Ana Hennino, Martin Friede, et al.
Pageof 4